Table 2.
Treatment within 3 months | Neoadjuvant chemotherapy | ≥10 Lymph nodes | Continent diversion | |||||
---|---|---|---|---|---|---|---|---|
Hospital Type | OR [CI] | P Value | OR [CI] | P Value | OR [CI] | P Value | OR [CI] | P Value |
Community | 1.0 | 1.0 | 1.0 | 1.0 | ||||
Comprehensive low volume | 1.07 [0.9–1.2] | 0.47 | 1.00 [0.8–1.2] | 0.99 | 1.00 [0.9–1.1] | 0.99 | 1.03 [0.8–1.3] | 0.82 |
Comprehensive high volume | 1.17 [0.9–1.5] | 0.23 | 1.15 [0.7–1.8] | 0.54 | 1.36 [1.04–1.8] | 0.03 | 1.19 [0.7–1.9] | 0.49 |
Academic low volume | 0.86 [0.7–1.01] | 0.07 | 0.96 [0.8–1.2] | 0.71 | 1.53 [1.3–1.8] | <0.001 | 1.10 [0.8–1.5] | 0.53 |
Academic high volume | 0.72 [0.6–0.9] | 0.001 | 1.60 [1.3–2.0] | <0.0001 | 3.14 [2.5–4.0] | <0.001 | 2.40 [1.8–3.3] | <0.0001 |
Adjusting for year, age, gender, race, Hispanic ethnicity, payor group, Charlson-Deyo score, income, education, tumor grade, analytic stage, urban/rural status, and facility location